Elena Kostik,Lijun Sun,Joanna Dziewiszek,Jun Y. Choi
申请号：
US12745096
公开号：
US08637704B2
申请日:
2008.11.28
申请国别(地区):
US
年份:
2014
代理人:
摘要：
At least 70% by weight of Compound 1 is the single crystalline form, Form A, Form C, or Form D, of the compound. A pharmaceutical composition comprises a pharmaceutically acceptable carrier or diluent, and compound 1, wherein at least 70% by weight of the compound is the single crystalline form, Form A, Form C, or Form D, of the compound. A method of treating a subject with cancer comprises administering to the subject an effective amount of compound 1 or the pharmaceutical composition.
